Cargando…

A Panel of E2F Target Gene Signature Predicting the Prognosis of Hepatocellular Carcinoma

Hepatocellular carcinoma is one of the most malignant tumors, and the therapeutic effects of traditional treatments are poor. It is urgent to explore and identify new biomarkers and therapeutic targets to develop novel treatments which are individualized and effective. Three hallmarks, including E2F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wenmin, Shi, Yongmei, Han, Tongqin, Liu, Caiyun, Cao, Xipeng, Shi, Guangjun, Zhu, Wenjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110819/ https://www.ncbi.nlm.nih.gov/pubmed/35591857 http://dx.doi.org/10.3389/fgene.2022.879299

Ejemplares similares

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
por: Meng, Tongyu, et al.
Publicado: (2022)

Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
por: Ding, Jianfeng, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Yang, Shengjie, et al.
Publicado: (2022)

Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2022)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer
por: Zhu, Wenjing, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma
por: Du, Xuanlong, et al.
Publicado: (2020)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
por: Li, Gen, et al.
Publicado: (2022)

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Identification and verification of a novel epigenetic-related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Wang, Chenchen, et al.
Publicado: (2022)

A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma
por: Chen, Jie, et al.
Publicado: (2020)

Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma
por: Jia, Yu, et al.
Publicado: (2020)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
por: Li, Yu, et al.
Publicado: (2023)

Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Song, Dingli, et al.
Publicado: (2022)

Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene–related signature associated with prognosis and therapy response
por: Chen, Lei, et al.
Publicado: (2022)

A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
por: Wu, Jianhua, et al.
Publicado: (2021)

Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma
por: Wang, Liangliang, et al.
Publicado: (2022)

Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes
por: Wang, Jianping, et al.
Publicado: (2023)

The Construction of a Prognostic Model Based on a Peptidyl Prolyl Cis–Trans Isomerase Gene Signature in Hepatocellular Carcinoma
por: Shi, Huadi, et al.
Publicado: (2021)

Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma
por: Huang, Yushen, et al.
Publicado: (2022)

Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Tang, Pingfei, et al.
Publicado: (2021)

Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma
por: Li, Debao, et al.
Publicado: (2023)

Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2021)

The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n84s079v3ft22omgcn3le3jsp4